These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 27239905

  • 1. Mucoadhesive microparticulates based on polysaccharide for target dual drug delivery of 5-aminosalicylic acid and curcumin to inflamed colon.
    Duan H, Lü S, Gao C, Bai X, Qin H, Wei Y, Wu X, Liu M.
    Colloids Surf B Biointerfaces; 2016 Sep 01; 145():510-519. PubMed ID: 27239905
    [Abstract] [Full Text] [Related]

  • 2. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
    Mura C, Nácher A, Merino V, Merino-Sanjuan M, Carda C, Ruiz A, Manconi M, Loy G, Fadda AM, Diez-Sales O.
    Int J Pharm; 2011 Sep 15; 416(1):145-54. PubMed ID: 21723929
    [Abstract] [Full Text] [Related]

  • 3. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
    Sareen R, Jain N, Rajkumari A, Dhar KL.
    Drug Deliv; 2016 Sep 15; 23(1):55-62. PubMed ID: 24758141
    [Abstract] [Full Text] [Related]

  • 4. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.
    Bautzová T, Rabišková M, Béduneau A, Pellequer Y, Lamprecht A.
    Eur J Pharm Biopharm; 2012 Jun 15; 81(2):379-85. PubMed ID: 22386911
    [Abstract] [Full Text] [Related]

  • 5. Co-delivery of zinc and 5-aminosalicylic acid from alginate/N-succinyl-chitosan blend microspheres for synergistic therapy of colitis.
    Duan H, Lü S, Qin H, Gao C, Bai X, Wei Y, Wu X, Liu M, Zhang X, Liu Z.
    Int J Pharm; 2017 Jan 10; 516(1-2):214-224. PubMed ID: 27851980
    [Abstract] [Full Text] [Related]

  • 6. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
    Beloqui A, Coco R, Memvanga PB, Ucakar B, des Rieux A, Préat V.
    Int J Pharm; 2014 Oct 01; 473(1-2):203-12. PubMed ID: 25014369
    [Abstract] [Full Text] [Related]

  • 7. Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
    Tozaki H, Fujita T, Odoriba T, Terabe A, Okabe S, Muranishi S, Yamamoto A.
    J Pharm Pharmacol; 1999 Oct 01; 51(10):1107-12. PubMed ID: 10579681
    [Abstract] [Full Text] [Related]

  • 8. Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid.
    Xu M, Sun M, Qiao H, Ping Q, Elamin ES.
    Int J Pharm; 2014 Jul 01; 468(1-2):165-71. PubMed ID: 24746693
    [Abstract] [Full Text] [Related]

  • 9. Eudragit S100 coated iron oxide-chitosan nanocomposites for colon targeting of 5-aminosalicylic acid ameliorate ulcerative colitis by improving intestinal barrier function and inhibiting NLRP3 inflammasome.
    Zhang D, Wan H, Zhao R, Zhang Y, Chen H.
    Int Immunopharmacol; 2024 Sep 30; 139():112661. PubMed ID: 39008936
    [Abstract] [Full Text] [Related]

  • 10. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.
    Zhang S, Kang L, Hu S, Hu J, Fu Y, Hu Y, Yang X.
    Int J Biol Macromol; 2021 Jan 15; 167():1598-1612. PubMed ID: 33220374
    [Abstract] [Full Text] [Related]

  • 11. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
    Mladenovska K, Raicki RS, Janevik EI, Ristoski T, Pavlova MJ, Kavrakovski Z, Dodov MG, Goracinova K.
    Int J Pharm; 2007 Sep 05; 342(1-2):124-36. PubMed ID: 17590293
    [Abstract] [Full Text] [Related]

  • 12. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
    Dubey R, Dubey R, Omrey P, Vyas SP, Jain SK.
    J Drug Target; 2010 Sep 05; 18(8):589-601. PubMed ID: 20088681
    [Abstract] [Full Text] [Related]

  • 13. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease.
    Oshi MA, Naeem M, Bae J, Kim J, Lee J, Hasan N, Kim W, Im E, Jung Y, Yoo JW.
    Carbohydr Polym; 2018 Oct 15; 198():434-442. PubMed ID: 30093020
    [Abstract] [Full Text] [Related]

  • 14. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
    Karrout Y, Dubuquoy L, Piveteau C, Siepmann F, Moussa E, Wils D, Beghyn T, Neut C, Flament MP, Guerin-Deremaux L, Dubreuil L, Deprez B, Desreumaux P, Siepmann J.
    J Control Release; 2015 Jan 10; 197():121-30. PubMed ID: 25445696
    [Abstract] [Full Text] [Related]

  • 15. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
    Quan JS, Jiang HL, Kim EM, Jeong HJ, Choi YJ, Guo DD, Yoo MK, Lee HG, Cho CS.
    Int J Pharm; 2008 Jul 09; 359(1-2):205-10. PubMed ID: 18490120
    [Abstract] [Full Text] [Related]

  • 16. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
    Naeem M, Choi M, Cao J, Lee Y, Ikram M, Yoon S, Lee J, Moon HR, Kim MS, Jung Y, Yoo JW.
    Drug Des Devel Ther; 2015 Jul 09; 9():3789-99. PubMed ID: 26229440
    [Abstract] [Full Text] [Related]

  • 17. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
    Kandula M, Sunil Kumar KB, Palanichamy S, Rampal A.
    Int Immunopharmacol; 2016 Nov 09; 40():443-451. PubMed ID: 27716592
    [Abstract] [Full Text] [Related]

  • 18. Development of Novel pH-Sensitive Eudragit Coated Beads Containing Curcumin-Mesalamine Combination for Colon-Specific Drug Delivery.
    Heikal EJ, Kaoud RM, Gad S, Mokhtar HI, Alattar A, Alshaman R, Zaitone SA, Moustafa YM, Hammady TM.
    Gels; 2023 Mar 23; 9(4):. PubMed ID: 37102876
    [Abstract] [Full Text] [Related]

  • 19. Mucoadhesive platforms for targeted delivery to the colon.
    Varum FJ, Veiga F, Sousa JS, Basit AW.
    Int J Pharm; 2011 Nov 25; 420(1):11-9. PubMed ID: 21856393
    [Abstract] [Full Text] [Related]

  • 20. In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
    Sawarkar SP, Deshpande SG, Bajaj AN, Nikam VS.
    AAPS PharmSciTech; 2015 Dec 25; 16(6):1445-54. PubMed ID: 26017284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.